Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-06-09
DOI
10.1093/neuonc/noab140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry
- (2020) James L Leach et al. NEURO-ONCOLOGY
- Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?
- (2020) Niveditha Manjunath et al. NEUROLOGICAL SCIENCES
- DIPG-68. ALPHA-THALASSEMIA X-LINKED MENTAL RETARDATION PROTEIN (ATRX) LOSS-OF-FUNCTION IN A MOUSE MODEL OF DIFFUSE INTRINSIC PONTINE GLIOMA
- (2020) Chen Shen et al. NEURO-ONCOLOGY
- Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations
- (2019) Zachary Miklja et al. NEURO-ONCOLOGY
- Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
- (2018) Lindsey M. Hoffman et al. JOURNAL OF CLINICAL ONCOLOGY
- External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry
- (2017) Sophie E. M. Veldhuijzen van Zanten et al. JOURNAL OF NEURO-ONCOLOGY
- The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease
- (2017) Joshua Baugh et al. JOURNAL OF NEURO-ONCOLOGY
- Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis
- (2017) Hadeel Hassan et al. JOURNAL OF NEURO-ONCOLOGY
- Characteristics of H3 K27M-mutant gliomas in adults
- (2017) David Meyronet et al. NEURO-ONCOLOGY
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria
- (2014) Marc H. Jansen et al. NEURO-ONCOLOGY
- Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy – Results of a United Kingdom phase II trial (CNS 2007 04)
- (2013) S. Bailey et al. EUROPEAN JOURNAL OF CANCER
- Molecular analysis of diffuse intrinsic brainstem gliomas in adults
- (2013) German Reyes-Botero et al. JOURNAL OF NEURO-ONCOLOGY
- Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma
- (2013) Sadhana Jackson et al. JOURNAL OF NEURO-ONCOLOGY
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
- (2012) Dong-Anh Khuong-Quang et al. ACTA NEUROPATHOLOGICA
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Diffuse intrinsic pontine glioma: poised for progress
- (2012) Katherine E. Warren Frontiers in Oncology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started